Cormorant Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,616,667	Closed	-$42.2M	–	51
2024 Q1	$42.2M	Buy	6,616,667 +1,166,667	+21%	+$7.44M	1.85%	15
2023 Q4	$35.1M	Buy	5,450,000 +5,057,833	+1,290%	+$32.6M	1.68%	18
2023 Q3	$914K	Hold	392,167	–	–	0.05%	47
2023 Q2	$933K	Hold	392,167	–	–	0.05%	57
2023 Q1	$722K	Hold	392,167	–	–	0.05%	65
2022 Q4	$745K	Hold	392,167	–	–	0.05%	67
2022 Q3	$839K	Hold	392,167	–	–	0.06%	64
2022 Q2	$1.11M	Hold	392,167	–	–	0.08%	68
2022 Q1	$1.64M	Hold	392,167	–	–	0.13%	70
2021 Q4	$2.04M	Hold	392,167	–	–	0.12%	70
2021 Q3	$2.57M	Hold	392,167	–	–	0.1%	80
2021 Q2	$2.6M	Sell	392,167 -30,000	-7%	-$199K	0.09%	86
2021 Q1	$2.42M	Hold	422,167	–	–	0.05%	101
2020 Q4	$3.77M	Hold	422,167	–	–	0.09%	84
2020 Q3	$4.91M	Sell	422,167 -57,821	-12%	-$673K	0.19%	70
2020 Q2	$7.69M	Hold	479,988	–	–	0.29%	58
2020 Q1	$2.88M	Hold	479,988	–	–	0.13%	60
2019 Q4	$6.34M	Hold	479,988	–	–	0.25%	50
2019 Q3	$5.96M	Sell	479,988 -220,012	-31%	-$2.73M	0.36%	47
2019 Q2	$11.3M	Sell	700,000 -150,000	-18%	-$2.42M	0.65%	42
2019 Q1	$26.8M	Buy	+850,000	New	+$26.8M	1.81%	21
2018 Q4	–	Sell	-1,326,136	Closed	-$40.7M	–	66
2018 Q3	$40.7M	Sell	1,326,136 -199,451	-13%	-$6.12M	2.64%	12
2018 Q2	$40.9M	Buy	+1,525,587	New	+$40.9M	3.02%	8